ArticleBMC medical imaging2025
Incidence and features of pulmonary track nodules after CT-guided lung biopsy with track sealing using gelatin sponge slurry.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTrack sealing (TS) with gelatin sponge slurry (GSS) is efficient in reducing pneumothorax after CT-guided lung biopsy. Nodule appearance along the pulmonary track after TS with GSS is a potential issue that has not been previously evaluated.
methodsA secondary analysis of two studies evaluating the efficacy of lung TS in 710 patients in reducing post-biopsy pneumothorax was performed. Among these patients, 377 had a follow-up CT within 2 months post-biopsy and were retrospectively included in this study (187 had TS with GSS, 83 with saline, and 107 no TS). Imaging findings of the pulmonary track were described. Binary logistic regression was used to determine factors associated with lung track nodules.
resultsMedian time between biopsy and follow-up CT was 29 days (range, 1-61). A pulmonary track nodule was detected on follow-up CT in 65/377 (17.2%) patients. Sixty three out of these 65 nodules (97%) were observed in the GSS group. Factors significantly associated with nodules on multivariate analysis were GSS use (odds ratio: 47.4, 95%CI:11.8-189.5; p < .0001) and track length (odds ratio: 1.03, 95%CI:1.01-1.05; p = .009). Nodules were solid in 100%, ovoid in 83.1%, well-defined in 87.7%, and had smooth borders in 96.9%. Thirty-three nodules were still visible on imaging > 6 weeks after the biopsy.
conclusionA pulmonary nodule along the biopsy track was detected on follow-up CT in 34% of cases when TS with GSS was performed. Recognition of these nodules on chest imaging is essential to avoid misinterpretation. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.